DRG 847

Chemotherapy without acute leukemia as secondary diagnosis with cc

  • Z08
    Encounter for follow-up examination after completed treatment for malignant neoplasm
  • Z51.11
    Encounter for antineoplastic chemotherapy
  • Z51.12
    Encounter for antineoplastic immunotherapy
ICD-10-CM Z08

Encounter for follow-up examination after completed treatment for malignant neoplasm

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
Applicable To
  • Medical surveillance following completed treatment
Type 1 Excludes
  • aftercare following medical care (Z43-Z49, Z51)
Use Additional
  • code to identify any acquired absence of organs (Z90.-)
ICD-10-CM Z51.11

Encounter for antineoplastic chemotherapy

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt
ICD-10-CM Z51.12

Encounter for antineoplastic immunotherapy

    2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code POA Exempt